BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22495673)

  • 1. Identification of critical residues involved in ligand binding and G protein signaling in human somatostatin receptor subtype 2.
    Parry JJ; Chen R; Andrews R; Lears KA; Rogers BE
    Endocrinology; 2012 Jun; 153(6):2747-55. PubMed ID: 22495673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association.
    Kong H; Raynor K; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Aug; 44(2):380-4. PubMed ID: 8102784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin and its receptor family.
    Patel YC
    Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gi alpha 3 and G(o) alpha selectively associate with the cloned somatostatin receptor subtype SSTR2.
    Law SF; Yasuda K; Bell GI; Reisine T
    J Biol Chem; 1993 May; 268(15):10721-7. PubMed ID: 8098703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspartic acid residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin-14 binding.
    Nehring RB; Meyerhof W; Richter D
    DNA Cell Biol; 1995 Nov; 14(11):939-44. PubMed ID: 7576180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2.
    Sharif N; Gendron L; Wowchuk J; Sarret P; Mazella J; Beaudet A; Stroh T
    Endocrinology; 2007 May; 148(5):2095-105. PubMed ID: 17272399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPCR somatostatin receptor extracellular loop 2 is a key ectodomain for making subtype-selective antibodies with agonist-like activities in the pancreatic neuroendocrine tumor BON cell line.
    Leu FP; Nandi M
    Pancreas; 2010 Nov; 39(8):1155-66. PubMed ID: 20531241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cloned somatostatin receptors SSTR4 and SSTR5.
    Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T
    Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
    Panetta R; Greenwood MT; Warszynska A; Demchyshyn LL; Day R; Niznik HB; Srikant CB; Patel YC
    Mol Pharmacol; 1994 Mar; 45(3):417-27. PubMed ID: 7908405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Tocopherol decreases the somatostatin receptor-effector system and increases the cyclic AMP/cyclic AMP response element binding protein pathway in the rat dentate gyrus.
    Hernández-Pinto AM; Puebla-Jiménez L; Arilla-Ferreiro E
    Neuroscience; 2009 Aug; 162(1):106-17. PubMed ID: 19393293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a critical aspartate residue in transmembrane domain three necessary for the binding of somatostatin to the somatostatin receptor SSTR2.
    Strnad J; Hadcock JR
    Biochem Biophys Res Commun; 1995 Nov; 216(3):913-21. PubMed ID: 7488212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An aspartate residue at the extracellular boundary of TMII and an arginine residue in TMVII of the gastrin-releasing peptide receptor interact to facilitate heterotrimeric G protein coupling.
    Donohue PJ; Sainz E; Akeson M; Kroog GS; Mantey SA; Battey JF; Jensen RT; Northup JK
    Biochemistry; 1999 Jul; 38(29):9366-72. PubMed ID: 10413511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor.
    Feuerbach D; Fehlmann D; Nunn C; Siehler S; Langenegger D; Bouhelal R; Seuwen K; Hoyer D
    Neuropharmacology; 2000 Jun; 39(8):1451-62. PubMed ID: 10818261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.
    Cervia D; Nunn C; Fehlmann D; Langenegger D; Schuepbach E; Hoyer D
    Br J Pharmacol; 2003 May; 139(1):109-21. PubMed ID: 12746229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling can be uncoupled from imaging of the somatostatin receptor type 2.
    Han L; Yang D; Kundra V
    Mol Imaging; 2007; 6(6):427-37. PubMed ID: 18053413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization-defective mutants of somatostatin receptor subtype 2 exert normal signaling functions in hematopoietic cells.
    Oomen SP; Hofland LJ; Lamberts SW; Löwenberg B; Touw IP
    FEBS Lett; 2001 Aug; 503(2-3):163-7. PubMed ID: 11513875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14.
    Ozenberger BA; Hadcock JR
    Mol Pharmacol; 1995 Jan; 47(1):82-7. PubMed ID: 7838136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of amino acid residues in transmembrane helices VI and VII of the lutropin/choriogonadotropin receptor involved in signaling.
    Fernandez LM; Puett D
    Biochemistry; 1996 Apr; 35(13):3986-93. PubMed ID: 8672431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists.
    Nunn C; Langenegger D; Hurth K; Schmidt K; Fehlmann D; Hoyer D
    Eur J Pharmacol; 2003 Apr; 465(3):211-8. PubMed ID: 12681432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase.
    Patel YC; Greenwood MT; Warszynska A; Panetta R; Srikant CB
    Biochem Biophys Res Commun; 1994 Jan; 198(2):605-12. PubMed ID: 7905265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.